Clinical Trial Update: Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating guanfacine for spatial neglect and impaired vigilance following stroke has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemispatial Neglect
• Stroke

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Imperial College London | Conditions: Stroke, Hemispatial Neglect | Phase 2 | Status: COMPLETED | Results posted: 2019-08-02